| 000 | 02650 a2200649 4500 | ||
|---|---|---|---|
| 005 | 20250516012613.0 | ||
| 264 | 0 | _c20111003 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1523-6536 | ||
| 024 | 7 |
_a10.1016/j.bbmt.2010.11.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTomblyn, Marcie R | |
| 245 | 0 | 0 |
_aAutologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. _h[electronic resource] |
| 260 |
_bBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _cJul 2011 |
||
| 300 |
_a1051-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xprevention & control |
| 650 | 0 | 4 | _aGraft vs Tumor Effect |
| 650 | 0 | 4 |
_aHLA Antigens _ximmunology |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHistocompatibility |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLiving Donors |
| 650 | 0 | 4 |
_aLymphoma, Follicular _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aSiblings |
| 650 | 0 | 4 |
_aTacrolimus _xtherapeutic use |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xadverse effects |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
| 650 | 0 | 4 | _aWhole-Body Irradiation |
| 700 | 1 | _aEwell, Marian | |
| 700 | 1 | _aBredeson, Christopher | |
| 700 | 1 | _aKahl, Brad S | |
| 700 | 1 | _aGoodman, Stacey A | |
| 700 | 1 | _aHorowitz, Mary M | |
| 700 | 1 | _aVose, Julie M | |
| 700 | 1 | _aNegrin, Robert S | |
| 700 | 1 | _aLaport, Ginna G | |
| 773 | 0 |
_tBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _gvol. 17 _gno. 7 _gp. 1051-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbmt.2010.11.004 _zAvailable from publisher's website |
| 999 |
_c20371546 _d20371546 |
||